Skip to content

Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, sold MPLT on Jul 17, 2026

Data as of Oct 16

▼ SELL$636K16,779 shares at $37.90Christopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.
Watch MPLT
Traded
Jul 17, 2026
Disclosed
Jul 17, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, sold MPLT on Jul 17, 2026TRADEDDISCLOSED
MPLTSimilar stocks (XLV — its sector index fund), rebased to MPLT's price on the disclosure day
MPLT since disclosure
−79.7%
after the sale
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund

Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$3.5Kdisclosed Jul 17 · filed 1 day after the trade
  2. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$1.5Mdisclosed Jul 17 · filed 1 day after the trade
  3. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$1Mdisclosed Jul 17 · filed 1 day after the trade
  4. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$682Kdisclosed Jul 17 · filed 2 days after the trade
  5. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$3.4Kdisclosed Jul 17 · filed 2 days after the trade
  6. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$1.6Mdisclosed Jul 17 · filed 2 days after the trade

See every trade on MPLT →